These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 398993)

  • 1. Enhanced release of 'PGI2-like' substance in experimental hypertension.
    Botha JH; Leary WP; Asmal AC
    Prostaglandins Med; 1979 Oct; 3(4):251-2. PubMed ID: 398993
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced release of a 'prostacyclin-like' substance from aortic strips of spontaneously hypertensive rats.
    Botha JH; Leary WP; Asmal AC
    Prostaglandins; 1980 Feb; 19(2):285-9. PubMed ID: 6992226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ibuprofen on systolic blood pressure and aortic PGI2 production in spontaneously hypertensive rats (SHR).
    Levy JV
    Biochem Biophys Res Commun; 1982 Dec; 109(4):1375-9. PubMed ID: 6762882
    [No Abstract]   [Full Text] [Related]  

  • 4. Release of prostaglandin I2-like activity from the rat aorta: effect of captopril, furosemide, and sodium.
    Sullivan JM; Patrick DR
    Prostaglandins; 1981 Oct; 22(4):575-85. PubMed ID: 7034053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular prostacyclin release and metabolic derangement in diabetes.
    Harrison HE; Johnson M
    Horm Metab Res Suppl; 1981; 11():43-9. PubMed ID: 7033096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of prostaglandins in the pathogenesis of hypertension.
    Markov CM
    Clin Sci Mol Med Suppl; 1978 Dec; 4():207s-210s. PubMed ID: 365432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced formation of PGI2, a potent hypotensive substance, by aortic rings and homogenates of the spontaneously hypertensive rat.
    Pace-Asciak CR; Carrara MC; Rangaraj G; Nicolaou KC
    Prostaglandins; 1978 Jun; 15(6):1005-12. PubMed ID: 358292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-II-stimulated release of thromboxane A2 and prostacyclin (PGI2) in isolated, perfused kidneys of spontaneously hypertensive rats.
    Shibouta Y; Inada Y; Terashita Z; Nishikawa K; Kikuchi S; Shimamoto K
    Biochem Pharmacol; 1979 Dec; 28(24):3601-9. PubMed ID: 394747
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of arachidonic acid on the basal release of prostaglandins E2 and I2 by rat arteries during the development of hypertension.
    Lukacsko P
    Clin Exp Hypertens A; 1983; 5(9):1471-83. PubMed ID: 6416720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanical reduction in pressure and pulse pressure decreases the ability of hypertensive rat aortas to produce 'PGI2-like' activity.
    Botha JH; Leary WP
    Prostaglandins Med; 1981 Mar; 6(3):267-8. PubMed ID: 7012875
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostacyclin (PGI2) release accompanying angiotensin conversion in rat mesenteric vasculature.
    Dusting GJ; Mullins EM; Nolan RD
    Eur J Pharmacol; 1981 Mar; 70(2):129-37. PubMed ID: 7021169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the occurrence of prostacyclin metabolites in plasma and vascular tissue as determined radioimmunologically.
    Peskar BM; Weiler H; Schmidberger P; Peskar BA
    FEBS Lett; 1980 Nov; 121(1):25-8. PubMed ID: 7007076
    [No Abstract]   [Full Text] [Related]  

  • 13. Acetylcholine stimulates the release of prostacyclin by rabbit aorta endothelium.
    Beetens JR; Van Hove C; Rampart M; Herman AG
    J Pharm Pharmacol; 1983 Apr; 35(4):251-2. PubMed ID: 6133938
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostacyclin, thromboplastin, and antiheparin activities of the rat aorta.
    Ts'ao CH; Krajewski DV; Galluzzo TS
    Proc Soc Exp Biol Med; 1981 Mar; 166(3):383-8. PubMed ID: 7010363
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of orally administered ethyl ester of eicosapentaenoic acid (EPA; C20:5, omega-3) on PGI2-like substance production by rat aorta.
    Hamazaki T; Hirai A; Terano T; Sajiki J; Kondo S; Fujita T; Tamura Y; Kumagai A
    Prostaglandins; 1982 Apr; 23(4):557-67. PubMed ID: 6810413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased vascular prostacyclin in experimental diabetes.
    Harrison HE; Reece AH; Johnson M
    Life Sci; 1978 Jul; 23(4):351-5. PubMed ID: 357875
    [No Abstract]   [Full Text] [Related]  

  • 17. Production of prostacyclin-like substance in stroke-prone and stroke-resistant spontaneously hypertensive rats.
    Okuma M; Yamori Y; Ohta K; Uchino H
    Prostaglandins; 1979 Jan; 17(1):1-7. PubMed ID: 35817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular eicosanoid production in experimental hypertensive rats with different mechanisms.
    Ishimitsu T; Uehara Y; Iwai J; Sugimoto T; Hirata Y; matsuoka H; Sugimoto T
    Prostaglandins Leukot Essent Fatty Acids; 1991 Jul; 43(3):179-84. PubMed ID: 1871182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between prostacyclin activity and pressure in the portal vein.
    Hamilton G; Phing RC; Hutton RA; Dandona P; Hobbs KE
    Hepatology; 1982; 2(2):236-42. PubMed ID: 7040200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of insulin treatment on prostacyclin in experimental diabetes.
    Harrison HE; Reece AH; Johnson M
    Diabetologia; 1980 Jan; 18(1):65-8. PubMed ID: 6988267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.